ACAD
47.7
-0.49
-1.02%
AEMD
9.7
+0.2
+2.11%
APRI
1.4
+0.02
+1.45%
ARNA
4.05
-0.01
-0.25%
ATEC
1.36
0.00
0.00%
CNAT
4.41
-0.08
-1.78%
CRXM
0.29
-0.01
-3.33%
CYTX
0.421
-0.005
-1.290%
DXCM
84.93
+0.4
+0.47%
GNMK
8.12
+0.08
+1.00%
HALO
23.31
+0.28
+1.22%
ILMN
214.31
-2.39
-1.10%
INNV
0.158
+0.003
+1.935%
INO
7.15
-0.1
-1.38%
ISCO
0.043
0.00
0.00%
ISIS
55.3
+1.34
+2.48%
LGND
109.31
+0.57
+0.52%
LPTN
0.252
-0.013
-4.8430%
MBVX
1.9
-0.11
-5.47%
MEIP
1.49
0.00
0.00%
MNOV
3.63
-0.1
-2.68%
MRTX
27.82
-0.14
-0.50%
MSTX
0.424
-0.006
-1.441%
NBIX
49.56
+0.57
+1.16%
NUVA
55.58
+0.39
+0.71%
ONCS
5.79
-0.19
-3.18%
ONVO
3.19
-0.16
-4.78%
OREX
3.86
-0.1
-2.53%
OTIC
25.23
-0.74
-2.85%
QDEL
20.85
+0.23
+1.12%
RCPT
228
-0.56
-0.25%
RGLS
7.77
-0.22
-2.75%
RMD
55.9
+0.5
+0.90%
SCIE
0.016
-0.002
-10.5556%
SPHS
0.802
-0.042
-4.976%
SRNE
20.75
-0.42
-1.98%
TROV
7.5
-0.38
-4.82%
VICL
0.65
+0.022
+3.4873%
ZGNX
19.49
-0.11
-0.56%
ACAD
47.7
-0.49
-1.02%
AEMD
9.7
+0.2
+2.11%
APRI
1.4
+0.02
+1.45%
ARNA
4.05
-0.01
-0.25%
ATEC
1.36
0.00
0.00%
CNAT
4.41
-0.08
-1.78%
CRXM
0.29
-0.01
-3.33%
CYTX
0.421
-0.005
-1.290%
DXCM
84.93
+0.4
+0.47%
GNMK
8.12
+0.08
+1.00%
HALO
23.31
+0.28
+1.22%
ILMN
214.31
-2.39
-1.10%
INNV
0.158
+0.003
+1.935%
INO
7.15
-0.1
-1.38%
ISCO
0.043
0.00
0.00%
ISIS
55.3
+1.34
+2.48%
LGND
109.31
+0.57
+0.52%
LPTN
0.252
-0.013
-4.8430%
MBVX
1.9
-0.11
-5.47%
MEIP
1.49
0.00
0.00%
MNOV
3.63
-0.1
-2.68%
MRTX
27.82
-0.14
-0.50%
MSTX
0.424
-0.006
-1.441%
NBIX
49.56
+0.57
+1.16%
NUVA
55.58
+0.39
+0.71%
ONCS
5.79
-0.19
-3.18%
ONVO
3.19
-0.16
-4.78%
OREX
3.86
-0.1
-2.53%
OTIC
25.23
-0.74
-2.85%
QDEL
20.85
+0.23
+1.12%
RCPT
228
-0.56
-0.25%
RGLS
7.77
-0.22
-2.75%
RMD
55.9
+0.5
+0.90%
SCIE
0.016
-0.002
-10.5556%
SPHS
0.802
-0.042
-4.976%
SRNE
20.75
-0.42
-1.98%
TROV
7.5
-0.38
-4.82%
VICL
0.65
+0.022
+3.4873%
ZGNX
19.49
-0.11
-0.56%
Home » SDBN Blog, SDBN Feed, Uncategorized

Good Morning from BIO!

Submitted by on May 18, 2009 – 4:44 am

Sunrise Atlanta on TwitpicYou may know I’m a blogger at the Biotechnology Industry Organization convention in Atlanta. I’m here and adjusting to the time change. I’m eager to cover stories about San Diego Biotech–we’ve got a lot going on here! Today Paul Grayson, CEO of Fate Therapeutics, and Ian Ratcliffe, CEO of Stemgent, will be speaking in the ‘Mastering Your (Cell) Fate: Stem Cells, iPSCs and the Future of Medicine’ session.’ Check out the BIO blog for the latest. I hope to speak with them, stay tuned! It’s raining off and on here, but I always forget how nice it is to see lots of trees.

Tags: , , , ,

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.


1 + = two